2017
M. G. Kramberger, Auestad, B., Garcia-Ptacek, S., Abdelnour, C., Olmo, J. Garre, Walker, Z., Lemstra, A. W., Londos, E., Blanc, F., Bonanni, L., McKeith, I., Winblad, B., de Jong, F. Jan, Nobili, F., Stefanova, E., Petrova, M., Falup-Pecurariu, C., Rektorova, I., Bostantjopoulou, S., Biundo, R., Weintraub, D., and Aarsland, D.,
“Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort.”,
J Alzheimers Dis, vol. 57, no. 3, pp. 787-795, 2017.
E. M. Shellington, Heath, M., Gill, D. P., and Petrella, R. J.,
“Long-Term Maintenance of Executive-Related Oculomotor Improvements in Older Adults with Self-Reported Cognitive Complaints Following a 24-Week Multiple Modality Exercise Program.”,
J Alzheimers Dis, vol. 58, no. 1, pp. 17-22, 2017.
G. Palmieri, Cocca, E., Gogliettino, M., Valentino, R., Ruvo, M., Cristofano, G., Angiolillo, A., Balestrieri, M., Rossi, M., and Di Costanzo, A.,
“Low Erythrocyte Levels of Proteasome and Acyl-Peptide Hydrolase (APEH) Activities in Alzheimer's Disease: A Sign of Defective Proteostasis?”,
J Alzheimers Dis, vol. 60, no. 3, pp. 1097-1106, 2017.
G. Lombardi, Berti, V., Tedde, A., Bagnoli, S., Piaceri, I., Polito, C., Lucidi, G., Ferrari, C., Ginestroni, A., Moretti, M., Pupi, A., Nacmias, B., and Sorbi, S.,
“Low Florbetapir PET Uptake and Normal Aβ1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier.”,
J Alzheimers Dis, vol. 57, no. 3, pp. 697-703, 2017.
G. Lombardi, Berti, V., Tedde, A., Bagnoli, S., Piaceri, I., Polito, C., Lucidi, G., Ferrari, C., Ginestroni, A., Moretti, M., Pupi, A., Nacmias, B., and Sorbi, S.,
“Low Florbetapir PET Uptake and Normal Aβ1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier.”,
J Alzheimers Dis, vol. 57, no. 3, pp. 697-703, 2017.
G. Lombardi, Berti, V., Tedde, A., Bagnoli, S., Piaceri, I., Polito, C., Lucidi, G., Ferrari, C., Ginestroni, A., Moretti, M., Pupi, A., Nacmias, B., and Sorbi, S.,
“Low Florbetapir PET Uptake and Normal Aβ1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier.”,
J Alzheimers Dis, vol. 57, no. 3, pp. 697-703, 2017.
Y. Chen, Sillaire, A. Rollin, Dallongeville, J., Skrobala, E., Wallon, D., Dubois, B., Hannequin, D., and Pasquier, F.,
“Low Prevalence and Clinical Effect of Vascular Risk Factors in Early-Onset Alzheimer's Disease.”,
J Alzheimers Dis, vol. 60, no. 3, pp. 1045-1054, 2017.
A. Oikonomidi, Tautvydaitė, D., Gholamrezaee, M. M., Henry, H., Bacher, M., and Popp, J.,
“Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia.”,
J Alzheimers Dis, vol. 60, no. 1, pp. 273-281, 2017.
A. T. van der Ven, Pape, J. C., Hermann, D., Schloesser, R., Genius, J., Fischer, N., Mößner, R., Scherbaum, N., Wiltfang, J., Rujescu, D., and Benninghoff, J.,
“Methylene Blue (Tetramethylthionine Chloride) Influences the Mobility of Adult Neural Stem Cells: A Potentially Novel Therapeutic Mechanism of a Therapeutic Approach in the Treatment of Alzheimer's Disease.”,
J Alzheimers Dis, vol. 57, no. 2, pp. 531-540, 2017.
J. Riancho, Vázquez-Higuera, J. Luis, Pozueta, A., Lage, C., Kazimierczak, M., Bravo, M., Calero, M., Gonalezález, A., Rodríguez, E., Lleo, A., and Sánchez-Juan, P.,
“MicroRNA Profile in Patients with Alzheimer's Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples.”,
J Alzheimers Dis, vol. 57, no. 2, pp. 483-491, 2017.
T. A. Lusardi, Phillips, J. I., Wiedrick, J. T., Harrington, C. A., Lind, B., Lapidus, J. A., Quinn, J. F., and Saugstad, J. A.,
“MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease.”,
J Alzheimers Dis, vol. 55, no. 3, pp. 1223-1233, 2017.
R. Tortelli, Lozupone, M., Guerra, V., Barulli, M. Rosaria, Imbimbo, B. P., Capozzo, R., Grasso, A., Tursi, M., Di Dio, C., Sardone, R., Giannelli, G., Seripa, D., Misciagna, G., Panza, F., and Logroscino, G.,
“Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline.”,
J Alzheimers Dis, vol. 59, no. 1, pp. 121-130, 2017.
J. A. Amorim, Canas, P. M., Tomé, A. R., Rolo, A. P., Agostinho, P., Palmeira, C. M., and Cunha, R. A.,
“Mitochondria in Excitatory and Inhibitory Synapses have Similar Susceptibility to Amyloid-β Peptides Modeling Alzheimer's Disease.”,
J Alzheimers Dis, vol. 60, no. 2, pp. 525-536, 2017.
E. Wawrziczny, Berna, G., Ducharme, F., Kergoat, M. - J., Pasquier, F., and Antoine, P.,
“Modeling the Distress of Spousal Caregivers of People with Dementia.”,
J Alzheimers Dis, vol. 55, no. 2, pp. 703-716, 2017.
S. J. B. Vos, van Boxtel, M. P. J., Schiepers, O. J. G., Deckers, K., de Vugt, M., Carrière, I., Dartigues, J. - F., Pérès, K., Artero, S., Ritchie, K., Galluzzo, L., Scafato, E., Frisoni, G. B., Huisman, M., Comijs, H. C., Sacuiu, S. F., Skoog, I., Irving, K., O'Donnell, C. A., Verhey, F. R. J., Visser, P. Jelle, and Köhler, S.,
“Modifiable Risk Factors for Prevention of Dementia in Midlife, Late Life and the Oldest-Old: Validation of the LIBRA Index.”,
J Alzheimers Dis, vol. 58, no. 2, pp. 537-547, 2017.
N. - M. Suhonen, Hallikainen, I., Hänninen, T., Jokelainen, J., Krüger, J., Hall, A., Pikkarainen, M., Soininen, H., and Remes, A. M.,
“The Modified Frontal Behavioral Inventory (FBI-mod) for Patients with Frontotemporal Lobar Degeneration, Alzheimer's Disease, and Mild Cognitive Impairment.”,
J Alzheimers Dis, vol. 56, no. 4, pp. 1241-1251, 2017.
E. Borland, Nägga, K., Nilsson, P. M., Minthon, L., Nilsson, E. D., and Palmqvist, S.,
“The Montreal Cognitive Assessment: Normative Data from a Large Swedish Population-Based Cohort.”,
J Alzheimers Dis, vol. 59, no. 3, pp. 893-901, 2017.
K. Jung Chang, Hong, C. Hyung, Lee, K. Soo, Kang, D. Ryong, Lee, J. Dong, Choi, S. Hye, Kim, S. Yoon, Na, D. L., Seo, S. Won, Kim, D. - K., Lee, Y., Chung, Y. Ki, Lim, K. Young, Noh, J. Sung, Park, J., and Son, S. Joon,
“Mortality Risk after Diagnosis of Early-Onset Alzheimer's Disease versus Late-Onset Alzheimer's Disease: A Propensity Score Matching Analysis.”,
J Alzheimers Dis, vol. 56, no. 4, pp. 1341-1348, 2017.
M. Montero-Odasso, Pieruccini-Faria, F., Bartha, R., Black, S. E., Finger, E., Freedman, M., Greenberg, B., Grimes, D. A., Hegele, R. A., Hudson, C., Kleinstiver, P. W., Lang, A. E., Masellis, M., McLaughlin, P. M., Munoz, D. P., Strother, S., Swartz, R. H., Symons, S., Tartaglia, M. Carmela, Zinman, L., Strong, M. J., and McIlroy, W.,
“Motor Phenotype in Neurodegenerative Disorders: Gait and Balance Platform Study Design Protocol for the Ontario Neurodegenerative Research Initiative (ONDRI).”,
J Alzheimers Dis, vol. 59, no. 2, pp. 707-721, 2017.
W. Khan, Giampietro, V., Banaschewski, T., Barker, G. J., Bokde, A. L. W., Büchel, C., Conrod, P., Flor, H., Frouin, V., Garavan, H., Gowland, P., Heinz, A., Ittermann, B., Lemaître, H., Nees, F., Paus, T., Pausova, Z., Rietschel, M., Smolka, M. N., Ströhle, A., Gallinat, J., Vellas, B., Soininen, H., Kloszewska, I., Tsolaki, M., Mecocci, P., Spenger, C., Villemagne, V. L., Masters, C. L., Muehlboeck, J. - S., Bäckman, L., Fratiglioni, L., Kalpouzos, G., Wahlund, L. - O., Schumann, G., Lovestone, S., Williams, S. C. R., Westman, E., and Simmons, A.,
“A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 56, no. 3, pp. 1159-1174, 2017.
W. Khan, Giampietro, V., Banaschewski, T., Barker, G. J., Bokde, A. L. W., Büchel, C., Conrod, P., Flor, H., Frouin, V., Garavan, H., Gowland, P., Heinz, A., Ittermann, B., Lemaître, H., Nees, F., Paus, T., Pausova, Z., Rietschel, M., Smolka, M. N., Ströhle, A., Gallinat, J., Vellas, B., Soininen, H., Kloszewska, I., Tsolaki, M., Mecocci, P., Spenger, C., Villemagne, V. L., Masters, C. L., Muehlboeck, J. - S., Bäckman, L., Fratiglioni, L., Kalpouzos, G., Wahlund, L. - O., Schumann, G., Lovestone, S., Williams, S. C. R., Westman, E., and Simmons, A.,
“A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 56, no. 3, pp. 1159-1174, 2017.
L. Li, Xu, S., Liu, L., Feng, R., Gong, Y., Zhao, X., Li, J., Cai, J., Feng, N., Wang, L., Wang, X., and Peng, Y.,
“Multifunctional Compound AD-35 Improves Cognitive Impairment and Attenuates the Production of TNF-α and IL-1β in an Aβ25-35-induced Rat Model of Alzheimer's Disease.”,
J Alzheimers Dis, vol. 56, no. 4, pp. 1403-1417, 2017.
J. Won Han, Lee, H., Hong, J. Woo, Kim, K., Kim, T., Byun, H. Jin, Ko, J. Won, Youn, J. Chul, Ryu, S. - H., Lee, N. - J., Pae, C. - U., and Kim, K. Woong,
“Multimodal Cognitive Enhancement Therapy for Patients with Mild Cognitive Impairment and Mild Dementia: A Multi- Center, Randomized, Controlled, Double-Blind, Crossover Trial.”,
J Alzheimers Dis, vol. 55, no. 2, pp. 787-796, 2017.
H. L. Golden, Clark, C. N., Nicholas, J. M., Cohen, M. H., Slattery, C. F., Paterson, R. W., Foulkes, A. J. M., Schott, J. M., Mummery, C. J., Crutch, S. J., and Warren, J. D.,
“Music Perception in Dementia.”,
J Alzheimers Dis, vol. 55, no. 3, pp. 933-949, 2017.
M. Gaubert, Villain, N., Landeau, B., Mézenge, F., Egret, S., Perrotin, A., Belliard, S., de la Sayette, V., Eustache, F., Desgranges, B., Chételat, G., and Rauchs, G.,
“Neural Correlates of Self-Reference Effect in Early Alzheimer's Disease.”,
J Alzheimers Dis, vol. 56, no. 2, pp. 717-731, 2017.
] 